These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 18922974)

  • 1. Suppression of hPOT1 in diploid human cells results in an hTERT-dependent alteration of telomere length dynamics.
    Possemato R; Timmons JC; Bauerlein EL; Wada N; Baldwin A; Masutomi K; Hahn WC
    Mol Cancer Res; 2008 Oct; 6(10):1582-93. PubMed ID: 18922974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue of an hTERT mutant defective in telomere elongation by fusion with hPot1.
    Armbruster BN; Linardic CM; Veldman T; Bansal NP; Downie DL; Counter CM
    Mol Cell Biol; 2004 Apr; 24(8):3552-61. PubMed ID: 15060173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human POT1 facilitates telomere elongation by telomerase.
    Colgin LM; Baran K; Baumann P; Cech TR; Reddel RR
    Curr Biol; 2003 May; 13(11):942-6. PubMed ID: 12781132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro.
    Zaug AJ; Podell ER; Cech TR
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10864-9. PubMed ID: 16043710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of the hPOT1 gene by RNA inference promotes apoptosis and inhibits proliferation and aggressive phenotype of gastric cancer cells, likely through up-regulating PinX1 expression.
    Wan SM; Tie J; Zhang YF; Guo J; Yang LQ; Wang J; Xia SH; Yang SM; Wang RQ; Fang DC
    J Clin Pathol; 2011 Dec; 64(12):1051-7. PubMed ID: 21778296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
    Kelleher C; Kurth I; Lingner J
    Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation.
    MacKenzie KL; Franco S; May C; Sadelain M; Moore MA
    Exp Cell Res; 2000 Sep; 259(2):336-50. PubMed ID: 10964501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere 1 (POT1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological features.
    Izgi A; Gunal A; Yalcin S; Gunduz U
    Biomed Pharmacother; 2014 Sep; 68(7):841-6. PubMed ID: 25194444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of telomerase modulation in human hematopoietic progenitor cells.
    Zimmermann S; Glaser S; Ketteler R; Waller CF; Klingm├╝ller U; Martens UM
    Stem Cells; 2004; 22(5):741-9. PubMed ID: 15342938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching human telomerase on and off with hPOT1 protein in vitro.
    Lei M; Zaug AJ; Podell ER; Cech TR
    J Biol Chem; 2005 May; 280(21):20449-56. PubMed ID: 15792951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells.
    Ning X; Yang S; Wang R; Zhang R; Guo L; Tie J; Cheng Y; Wang G; Wan S; Fang D
    Eur J Cancer Prev; 2010 Sep; 19(5):345-51. PubMed ID: 20517159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomeric 3'-overhang length is associated with the size of telomeres.
    Rahman R; Forsyth NR; Cui W
    Exp Gerontol; 2008 Apr; 43(4):258-65. PubMed ID: 18280685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase maintains telomere structure in normal human cells.
    Masutomi K; Yu EY; Khurts S; Ben-Porath I; Currier JL; Metz GB; Brooks MW; Kaneko S; Murakami S; DeCaprio JA; Weinberg RA; Stewart SA; Hahn WC
    Cell; 2003 Jul; 114(2):241-53. PubMed ID: 12887925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase activation induces elongation of the telomeric single-stranded overhang, but does not prevent chromosome aberrations in human vascular endothelial cells.
    Anno K; Hayashi A; Takahashi T; Mitsui Y; Ide T; Tahara H
    Biochem Biophys Res Commun; 2007 Feb; 353(4):926-32. PubMed ID: 17207773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span.
    Vaziri H; Benchimol S
    Curr Biol; 1998 Feb; 8(5):279-82. PubMed ID: 9501072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection.
    Lei M; Podell ER; Cech TR
    Nat Struct Mol Biol; 2004 Dec; 11(12):1223-9. PubMed ID: 15558049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase with mutated catalytic motifs has dominant negative effects on telomerase activity and inhibits cell growth.
    Rahman R; Mo L; Cui W
    Biochem Biophys Res Commun; 2006 Nov; 350(3):796-802. PubMed ID: 17026956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase enzymatic component hTERT shortens long telomeres in human cells.
    Zheng YL; Zhang F; Sun B; Du J; Sun C; Yuan J; Wang Y; Tao L; Kota K; Liu X; Schlegel R; Yang Q
    Cell Cycle; 2014; 13(11):1765-76. PubMed ID: 24721976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient expression of human telomerase extends the life span of normal human fibroblasts.
    Steinert S; Shay JW; Wright WE
    Biochem Biophys Res Commun; 2000 Jul; 273(3):1095-8. PubMed ID: 10891377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
    Babizhayev MA; Yegorov YE
    J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.